Affected Systems |
|
|
behavior/neurological
|
√
|
impaired coordination
|
√
|
endocrine/exocrine glands
|
√
|
thymus hypoplasia
|
√
|
decreased thymocyte number
|
√
|
growth/size/body
|
√
|
decreased body size
|
√
|
decreased body weight
|
√
|
postnatal growth retardation
|
√
|
hematopoietic system
|
√
|
thymus hypoplasia
|
√
|
decreased bone marrow cell number
|
√
|
decreased hematopoietic stem cell number
|
√
|
abnormal lymphocyte morphology
|
√
|
decreased pro-B cell number
|
√
|
abnormal B cell number
|
√
|
increased follicular B cell number
|
√
|
decreased B cell number
|
√
|
decreased immature B cell number
|
√
|
decreased transitional stage T1 B cell number
|
√
|
decreased transitional stage T2 B cell number
|
√
|
decreased mature B cell number
|
√
|
decreased B-1a cell number
|
√
|
decreased marginal zone B cell number
|
√
|
decreased pre-B cell number
|
√
|
abnormal T cell number
|
√
|
decreased thymocyte number
|
√
|
decreased double-positive T cell number
|
√
|
decreased CD4-positive, alpha-beta T cell number
|
√
|
decreased CD8-positive, alpha-beta T cell number
|
√
|
spleen hypoplasia
|
√
|
decreased IgG2a level
|
√
|
immune system
|
√
|
thymus hypoplasia
|
√
|
abnormal lymphocyte morphology
|
√
|
decreased pro-B cell number
|
√
|
abnormal B cell number
|
√
|
increased follicular B cell number
|
√
|
decreased B cell number
|
√
|
decreased immature B cell number
|
√
|
decreased transitional stage T1 B cell number
|
√
|
decreased transitional stage T2 B cell number
|
√
|
decreased mature B cell number
|
√
|
decreased B-1a cell number
|
√
|
decreased marginal zone B cell number
|
√
|
decreased pre-B cell number
|
√
|
abnormal T cell number
|
√
|
decreased thymocyte number
|
√
|
decreased double-positive T cell number
|
√
|
decreased CD4-positive, alpha-beta T cell number
|
√
|
decreased CD8-positive, alpha-beta T cell number
|
√
|
spleen hypoplasia
|
√
|
decreased IgG2a level
|
√
|
mortality/aging
|
√
|
premature death
|
√
|
skeleton
|
√
|
fragile skeleton
|
√
|